Exact Mass: 528.2207
Exact Mass Matches: 528.2207
Found 201 metabolites which its exact mass value is equals to given mass value 528.2207
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside
16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside belongs to the class of organic compounds known as diterpene glycosides. These are diterpenoids in which an isoprene unit is glycosylated. 16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside is found in cereals and cereal products. 16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside is a constituent of rice (Oryza sativa) flower anthers. Constituent of rice (Oryza sativa) flower anthers. 16,17-Dihydro-16a,17-dihydroxygibberellin A4 17-glucoside is found in cereals and cereal products.
Dutasteride
Dutasteride belongs to a class of drugs called 5-alpha-reductase inhibitors, which block the action of the 5-alpha-reductase enzymes that convert testosterone into dihydrotestosterone (DHT). Finasteride also belongs to this group, but while dutasteride inhibits both isoforms of 5-alpha reductase, finasteride inhibits only one. Even so, a clinical study done by GlaxoSmithKline, the EPICS trial, did not find dutasteride to be more effective than finasteride in treating BPH. [Wikipedia] G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2-((5-Chloro-2-((4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide
Felotaxel
Cinnabarone
bistratamide G
A homodetic cyclic peptide that consists of L-valine as the amino acid residue. It is isolated from Lissoclinum bistratum and exhibits antitumour activity against the human colon tumour cell line.
1,3,6,8-Tetramethyl-4,5-divinyl-9,10-dihydro-1,3-biphenanthrene-2,2,7,7-tetrol
Dutasteride
G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
C25H36O12_2,7-Octadienoic acid, 6-hydroxy-2,6-dimethyl-, (1aR,1bS,2S,5aS,6R,6aS)-2-(beta-D-glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-5a-hydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-6-yl ester, (2E,6S)
[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate
[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate_major
[(1aR,1bS,2S,5aS,6R,6aS)-5a-hydroxy-1a-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1b,2,6,6a-tetrahydrooxireno[1,2]cyclopenta[4,5-b]pyran-6-yl] (2E,6S)-6-hydroxy-2,6-dimethylocta-2,7-dienoate_35.8\\%
Ala Glu Phe Tyr
Ala Glu Tyr Phe
Ala Phe Glu Tyr
Ala Phe Tyr Glu
Ala Tyr Glu Phe
Ala Tyr Phe Glu
Cys His Asn Arg
Cys His Arg Asn
Cys Asn His Arg
Cys Asn Arg His
Cys Arg His Asn
Cys Arg Asn His
Asp Phe Phe Thr
Asp Phe Thr Phe
Asp Thr Phe Phe
Glu Ala Phe Tyr
Glu Ala Tyr Phe
Glu Phe Ala Tyr
Glu Phe Phe Ser
Glu Phe Ser Phe
Glu Phe Tyr Ala
Glu Ser Phe Phe
Glu Tyr Ala Phe
Glu Tyr Phe Ala
Phe Ala Glu Tyr
Phe Ala Tyr Glu
Phe Asp Phe Thr
Phe Asp Thr Phe
Phe Glu Ala Tyr
Phe Glu Phe Ser
Phe Glu Ser Phe
Phe Glu Tyr Ala
Phe Phe Asp Thr
Phe Phe Glu Ser
Phe Phe Ser Glu
Phe Phe Thr Asp
Phe Ser Glu Phe
Phe Ser Phe Glu
Phe Thr Asp Phe
Phe Thr Phe Asp
Phe Tyr Ala Glu
Phe Tyr Glu Ala
His Cys Asn Arg
His Cys Arg Asn
His Met Asn Gln
His Met Gln Asn
His Asn Cys Arg
His Asn Met Gln
His Asn Gln Met
His Asn Arg Cys
His Gln Met Asn
His Gln Asn Met
His Arg Cys Asn
His Arg Asn Cys
Met His Asn Gln
Met His Gln Asn
Met Asn His Gln
Met Asn Gln His
Met Gln His Asn
Met Gln Asn His
Asn Cys His Arg
Asn Cys Arg His
Asn His Cys Arg
Asn His Met Gln
Asn His Gln Met
Asn His Arg Cys
Asn Met His Gln
Asn Met Gln His
Asn Gln His Met
Asn Gln Met His
Asn Arg Cys His
Asn Arg His Cys
Pro Ser Tyr Tyr
Pro Tyr Ser Tyr
Pro Tyr Tyr Ser
Gln His Met Asn
Gln His Asn Met
Gln Met His Asn
Gln Met Asn His
Gln Asn His Met
Gln Asn Met His
Arg Cys His Asn
Arg Cys Asn His
Arg His Cys Asn
Arg His Asn Cys
Arg Asn Cys His
Arg Asn His Cys
Ser Glu Phe Phe
Ser Phe Glu Phe
Ser Phe Phe Glu
Ser Pro Tyr Tyr
Ser Tyr Pro Tyr
Ser Tyr Tyr Pro
Thr Asp Phe Phe
Thr Phe Asp Phe
Thr Phe Phe Asp
Tyr Ala Glu Phe
Tyr Ala Phe Glu
Tyr Glu Ala Phe
Tyr Glu Phe Ala
Tyr Phe Ala Glu
Tyr Phe Glu Ala
Tyr Pro Ser Tyr
Tyr Pro Tyr Ser
Tyr Ser Pro Tyr
Tyr Ser Tyr Pro
Tyr Tyr Pro Ser
Tyr Tyr Ser Pro
16,17-Dihydro-16a,17-dihydroxygibberellin A4 17-glucoside
(+)-4,5-Bis[hydroxy(diphenyl)methyl]-2-methyl-2-phenyl-1,3-dioxolane
dexamethasone acefurate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Celesticetin A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides
[(2S,3S,4S,6R)-6-[[(1S,3R,4R)-3-ethyl-3,4,10,12-tetrahydroxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-dimethylazanium
(1S)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(1-oxo-2-phenylethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R,3aS,3bS,5aR,9aR,9bR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
[7-(Acetyloxymethyl)-4,5-dihydroxy-3,11,11,14-tetramethyl-15-oxo-6-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] deca-2,4,6,8-tetraynoate
16,17-Dihydro-16alpha,17-dihydroxygibberellin A4 17-glucoside
CID 10369659
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides